Merus B.v.
Clinical trials sponsored by Merus B.v., explained in plain language.
-
New hope for advanced head and neck cancer patients in major phase 3 trial
Disease control Recruiting nowThis study is testing whether adding a new drug called petosemtamab to standard pembrolizumab treatment works better for advanced head and neck cancer. It will involve about 500 adults whose cancer has returned or spread and who haven't had prior treatment for metastatic disease.…
Phase: PHASE3 • Sponsor: Merus B.V. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New Two-Drug attack on advanced lung cancer enters testing
Disease control Recruiting nowThis study is testing whether adding a new drug called petosemtamab to an existing immunotherapy (pembrolizumab) is safe and more effective for people newly diagnosed with advanced non-small cell lung cancer. It will involve about 180 adults whose cancer has spread and who have n…
Phase: PHASE2 • Sponsor: Merus B.V. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New hope for Tough-to-Treat head and neck cancer: major trial tests promising drug
Disease control Recruiting nowThis study is testing an experimental drug called petosemtamab for people with advanced head and neck cancer that has spread or returned after standard treatments. It will compare petosemtamab against other single-drug treatments chosen by doctors to see which works better. The m…
Phase: PHASE3 • Sponsor: Merus B.V. • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC